|Bid||0.34 x 3000|
|Ask||0.38 x 10000|
|Day's Range||0.35 - 0.36|
|52 Week Range||0.16 - 4.75|
|PE Ratio (TTM)||-0.23|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||8.00|
SAN RAMON, Calif., Sept. 11, 2017-- Galena Biopharma, Inc., a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced it has reaffirmed ...
Galena Biopharma Inc will pay more than $7.55 million to resolve charges it paid kickbacks to doctors to induce them to prescribe its opioid-based pain medication Abstral to patients, the U.S. Department of Justice said on Friday. The settlement with Galena comes as federal authorities try to combat an epidemic of opioid abuse, which President Donald Trump last month declared a national emergency.
The San Ramon, California-based company said it had a loss of 22 cents per share. Losses, adjusted to account for discontinued operations and non-recurring costs, were 16 cents per share. In the final ...